New Precision Medicine Platform Supports Disease Areas With Unmet Medical Needs
The new biorepository can be instrumental in genetic and biomarker identification for patient populations with rapid disease progression.
Read MorePosted by Andy Lundin | Jan 4, 2024 | Diagnostic Technologies |
The new biorepository can be instrumental in genetic and biomarker identification for patient populations with rapid disease progression.
Read MorePosted by Andy Lundin | Jan 3, 2024 | Melanoma |
The combined biomarkers, AMBRA1 and loricrin can be used to reliably stratify stage I and II melanomas at genuine low risk of progression.
Read MorePosted by Andy Lundin | Jan 3, 2024 | Covid 19 |
This research aims to improve the understanding of how maternal antibodies against SARS-CoV-2 are transferred to and persist in newborns.
Read MorePosted by Andy Lundin | Jan 3, 2024 | Covid 19, POC Rapid Assays |
Sekisui formalized an exclusive distribution agreement with Aptitude Medical Systems to sell the Aptitude Metrix COVID Test in the U.S.
Read MorePosted by Andy Lundin | Dec 28, 2023 | Kidney Disease, Standards |
The NIST released new standard reference material that uses urine to check for kidney disease and conditions that affect kidney function.
Read More